Related Experiment Video
Updated: Jul 18, 2026

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway
John Cijiang He1, Ting-Chi Lu, Margaret Fleet
1Department of Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA. cijiang.he@mssm.edu
Abstract:
HIV-associated nephropathy is characterized by renal podocyte proliferation and dedifferentiation. This study found that all-trans retinoic acid (atRA) reverses the effects of HIV-1 infection in podocytes. Treatment with atRA reduced cell proliferation rate by causing G1 arrest and restored the expression of the differentiation markers (synaptopodin, nephrin, podocin, and WT-1) in HIV-1-infected podocytes. It is interesting that both atRA and 9-cis RA increased intracellular cAMP levels in podocytes. Podocytes expressed most isoforms of retinoic acid receptors (RAR) and retinoid X receptors (RXR) with the exception of RXRgamma. RARalpha antagonists blocked atRA-induced cAMP production and its antiproliferative and prodifferentiation effects on podocytes, suggesting that RARalpha is required. For determination of the effect of increased intracellular cAMP on HIV-infected podocytes, cells were stimulated with either forskolin or 8-bromo-cAMP. Both compounds inhibited cell proliferation significantly and restored synaptopodin expression in HIV-infected podocytes. The effects of atRA were abolished by Rp-cAMP, an inhibitor of the cAMP/protein kinase A pathway and were enhanced by rolipram, an inhibitor of phosphodiesterase 4, suggesting that the antiproliferative and prodifferentiation effects of atRA on HIV-infected podocytes are cAMP dependent. Furthermore, both atRA and forskolin suppressed HIV-induced mitogen-activated protein kinase 1 and 2 and Stat3 phosphorylation. In vivo, atRA reduced proteinuria, cell proliferation, and glomerulosclerosis in HIV-1-transgenic mice. These findings suggest that atRA reverses the abnormal phenotype in HIV-1-infected podocytes by stimulating RARalpha-mediated intracellular cAMP production. These results demonstrate the mechanism by which atRA reverses the proliferation of podocytes that is induced by HIV-1.
Insights
All-trans retinoic acid (atRA) reverses HIV-1 podocyte damage by increasing cAMP levels, restoring differentiation markers and inhibiting proliferation. This treatment also reduced proteinuria and glomerulosclerosis in HIV-1-transgenic mice.
Area of Science:
- Nephrology
- Molecular Biology
- Virology
Background:
- HIV-associated nephropathy involves renal podocyte proliferation and dedifferentiation.
- Understanding the molecular mechanisms underlying podocyte dysfunction in HIV-1 infection is crucial.
Purpose of the Study:
- To investigate the therapeutic potential of all-trans retinoic acid (atRA) in reversing HIV-1-induced podocyte abnormalities.
- To elucidate the intracellular signaling pathways, particularly cAMP-mediated pathways, involved in atRA's effects on HIV-1-infected podocytes.
Main Methods:
- Treatment of HIV-1-infected podocytes with atRA and other retinoids.
- Assessment of cell proliferation, differentiation markers (synaptopodin, nephrin, podocin, WT-1), and intracellular cAMP levels.
- Pharmacological manipulation using receptor antagonists (RARalpha antagonists), cAMP analogs (forskolin, 8-bromo-cAMP), and pathway inhibitors (Rp-cAMP, rolipram).
- In vivo studies using HIV-1-transgenic mice to evaluate proteinuria, cell proliferation, and glomerulosclerosis.
Main Results:
- atRA treatment reduced proliferation and restored differentiation markers in HIV-1-infected podocytes.
- atRA and 9-cis RA increased intracellular cAMP levels; this effect was RARalpha-dependent.
- Exogenous cAMP stimulation mimicked atRA's antiproliferative and differentiation-restoring effects.
- atRA's effects were dependent on the cAMP/protein kinase A pathway and involved suppression of MAPK and Stat3 phosphorylation.
- In vivo, atRA ameliorated proteinuria, proliferation, and glomerulosclerosis in HIV-1-transgenic mice.
Conclusions:
- atRA effectively reverses the detrimental effects of HIV-1 on podocytes through a mechanism involving RARalpha-mediated cAMP production.
- The findings highlight the therapeutic potential of atRA for managing HIV-associated nephropathy.
- Targeting the cAMP pathway offers a promising strategy for treating HIV-1-induced kidney disease.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
09:26In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
cAMP-dependent Protein Kinase Pathways
Inhibition of Cdk Activity
Inhibition of CDK Activity
Inhibitors of Viral Protein Synthesis